Rebound from COVID-19

Rebound from COVID-19In the aftermath of the pandemic, the nation’s resiliency to preventing further resurgence of COVID-19 infection and the key to making a comeback from the current crisis rests largely with private and public sectors. Personalized, preventive care that ensures better outcomes and individual safety hold the keys to success in this rebound environment.

At-home rapid PCR and antigen COVID-19 tests enable more frequent risk stratification, realtime health status and improved population health throughout the enterprise. As fears of new variants linger, regular testing is a necessary component of preventive care and speeds the transition to “normal.” It is becoming evident that benefits providers, payers and administrators need strong assurances of health and safety, which is further fueling a massive demand for affordable, adaptable, accurate at-home or onsite, rapid testing solutions.

Continue Reading [PDF]


Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees, CEO Michael Gorton Panel Presenter

DALLAS—(BUSINESS WIRE)—Recuro Health(Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes...